If you are wondering how lung cancer is detected, your doctor has many options for getting a diagnosis. Lung cancer tests include imaging scans, tests of mucus from your lungs, and a biopsy.

Lung cancer starts in your lungs and can spread to other parts of your body. There are more than 20 kinds of lung cancer. Some other conditions can have similar warning signs to lung cancer.

rare type of small cell lung cancer that primarily affects younger people who have never ... Aug. 23, 2024 — A team of researchers has created a digital pathology platform based on artificial ...

Electronic "nose" analysis of exhaled breath achieved 80-90% accuracy for detecting lung cancer in patients with suspicious clinical or radiologic findings, a large prospective study showed.

Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Beyond Standard of Care NYU lung cancer specialists discuss advances in adjuvant therapy for non–small cell lung cancer, including ...

Lung cancer’s symptoms ... Janssen is also looking for collaborators to harness Japanese diagnostic pathology and radiology databases to better understand the genomic and molecular bases ...

The firm secured a Japanese patent for the CyPath® Lung test, marking a significant step in its global expansion strategy. Furthermore, the company reported an EBITDA of -$7.62 million in the ...

Portable multiphoton microscopy system uses femtosecond laser pulses to create pathology-quality diagnostic images ...

Previous estimates had put this risk closer to ... Rates of Breast and Colorectal Cancer Screening Nearly Four-Fold Higher Than Lung Cancer Screening Among Those Eligible Apr. 2, 2025 — Lung ...

Recently, we found, using a cigarette carcinogen-induced lung cancer model, that soy protein isolate (SPI) was superior to casein in preventing lung cancer. In this study, we have attempted to ...

Interstitial lung abnormalities (ILAs) are increasingly recognised due to the widespread use of low-dose computed tomography ...

Vergent Bioscience has completed subject enrolment for its VISUALIZE trial, which is designed to assess the efficacy and safety of abenacianine for injection (VGT-309) in lung cancer patients.